Skip to content
Disclosery

Alerce Investment Management, L.P.

Follow

13F filer, CIK 1844002, Chicago, IL

Alerce Investment Management, L.P. reported $76,866,930 across 6 holdings for the quarter ended 2023-06-30, in a 13F-HR filed 2023-08-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000895345-23-000465

Period
2023-06-30
Reported value
$76.9M
Holdings
6
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q2 2023

Share positions as resolved from 13F-HR 0000895345-23-000465, largest first. % of portfolio is the value over $76,866,930, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 7,056,024 shares; 2023Q2: 7,056,024 shares 7,056,024$24.8M32.31%0Timeline
AMERICAN WELL CORPAMERICAN WELL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 10,475,717 shares; 2023Q2: 10,475,717 shares 10,475,717$22M28.62%0
AKBAAKEBIA THREAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 16,205,119 shares; 2023Q2: 16,205,119 shares 16,205,119$14.8M19.29%0Timeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,630,830 shares; 2023Q2: 1,630,830 shares 1,630,830$11.2M14.51%0Timeline
ASSEMBLY BIOSCIENCES INCASSEMBLY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,227,500 shares; 2023Q2: 2,227,500 shares 2,227,500$2.56M3.33%0
RNTXREIN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 830,466 shares; 2023Q2: 830,466 shares 830,466$1.49M1.93%0Timeline

How Q2 2023 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000895345-23-000465 base2023-08-14acceptance time not in the bulk data set